SMSPHARMA.BOSMSPHARMA.BOBSE
Loading
Operating Income ScalingExpanding
Percentile Rank93
3Y CAGR+84.4%
5Y CAGR+6.5%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+84.4%/yr
vs -25.9%/yr prior
5Y CAGR
+6.5%/yr
Recent acceleration
Acceleration
+110.3pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.34B | +29.5% |
| 2025 | $1.03B | -22.9% |
| 2024 | $1.34B | +528.0% |
| 2023 | $213.40M | -73.0% |
| 2022 | $789.84M | -19.1% |
| 2021 | $976.68M | +68.4% |
| 2020 | $580.09M | -18.2% |
| 2019 | $708.74M | -3.5% |
| 2018 | $734.75M | -6.4% |
| 2017 | $784.87M | - |